| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |